Could a Vitamin-Like pill slow down a devastating nerve disease?
NCT ID NCT04562831
Summary
This study is testing whether a dietary supplement containing two natural compounds, Nicotinamide Riboside and Pterostilbene, can slow the progression of ALS (Lou Gehrig's disease). It involves 380 people with ALS who will take either the supplement or a placebo pill. The goal is to see if this combination can delay worsening of symptoms, improve quality of life, and potentially increase survival time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Akershus University Hospital
Lørenskog, Norway
-
Haukeland University Hospital
Bergen, Norway
-
Helse Fonna HF
Haugesund, Norway
-
Helse Førde HF
Førde, Norway
-
Oslo University Hospital
Oslo, Norway
-
St.Olavs Hospital HF
Trondheim, Norway
-
Stavanger University Hospital
Stavanger, Norway
-
Universitetssykehuset Nord-Norge
Tromsø, Norway
-
Vestre Viken HF
Drammen, Norway
Conditions
Explore the condition pages connected to this study.